rFVIII

Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq® in Previously Untreated Patients With Severe Haemophilia A

LACHEN, Switzerland:  Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated…

Read More »